Asia Executives To Watch: New FDA China Director Named Amid ICH Push
Executive Summary
The US FDA has sent its country director from Peru to build a closer relationship with the China FDA, while the CFDA's own medical device center is also going through a series of leadership changes.
You may also be interested in...
FDA Tip-Toes In China To Push Data Integrity, Harmonization
US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.